Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...

From oral PrEP, to injectables, rings, and implants, this year's HIV Research for Prevention conference was all about options ...

A multiomic analysis led by the IrsiCaixa AIDS Research Institute has uncovered genetic and immune mechanisms in some ...

Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...

Tennessee Gov. Bill Lee made waves in early 2023, when he rejected millions of dollars in federal HIV prevention programming.

Gilead has grown to become a leader in the fight against HIV and has announced efforts to improve access to a new, highly ...

Two posters compared health care resource utilization (HCRU) and financial burdens of people living with HIV with a non-HIV ...

In the complex landscape of chronic health conditions, living with HIV while recovering from a stroke presents a unique set ...

Fostemsavir plus optimized background therapy was associated with improvements in immune biomarkers among HTE patients with MDR HIV infection.

The national HIV prevalence was 16. 3% among adults aged 15 years and older, translating to an estimated 7. 4 million adults ...

The Centers for Disease Control and Prevention provides funding for HIV prevention for the populations at the highest risk of ...

Gilead and Merck & Co. have guided their once-weekly HIV combination therapy past another milestone, linking the cocktail to ...